HK1108889A1 - Novel compound having lipase inhibitory activity - Google Patents
Novel compound having lipase inhibitory activityInfo
- Publication number
- HK1108889A1 HK1108889A1 HK08102623.3A HK08102623A HK1108889A1 HK 1108889 A1 HK1108889 A1 HK 1108889A1 HK 08102623 A HK08102623 A HK 08102623A HK 1108889 A1 HK1108889 A1 HK 1108889A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitory activity
- novel compound
- lipase inhibitory
- lipase
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/243—Liquid, semi-liquid or non-dried semi-solid coffee extract preparations; Coffee gels; Liquid coffee in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Botany (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Tea And Coffee (AREA)
- Non-Alcoholic Beverages (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004182471A JP5475938B2 (ja) | 2004-06-21 | 2004-06-21 | リパーゼ阻害活性を有する新規化合物 |
PCT/JP2005/011258 WO2005123725A1 (ja) | 2004-06-21 | 2005-06-20 | リパーゼ阻害活性を有する新規化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1108889A1 true HK1108889A1 (en) | 2008-05-23 |
Family
ID=35509613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08102623.3A HK1108889A1 (en) | 2004-06-21 | 2008-03-06 | Novel compound having lipase inhibitory activity |
Country Status (10)
Country | Link |
---|---|
US (2) | US20110118344A1 (xx) |
EP (1) | EP1783127B1 (xx) |
JP (1) | JP5475938B2 (xx) |
KR (1) | KR101342288B1 (xx) |
CN (1) | CN101094851B (xx) |
ES (1) | ES2571131T3 (xx) |
HK (1) | HK1108889A1 (xx) |
SG (1) | SG153840A1 (xx) |
TW (1) | TWI385166B (xx) |
WO (1) | WO2005123725A1 (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2172537B1 (en) * | 2007-07-13 | 2014-06-18 | Ogawa & Co., Ltd. | Flavor or fragrance deterioration inhibitor |
JP5579789B2 (ja) * | 2007-09-26 | 2014-08-27 | サントリー食品インターナショナル株式会社 | 茶抽出物、茶飲料及びそれらの製造方法 |
JP5238993B2 (ja) * | 2007-09-26 | 2013-07-17 | サントリー食品インターナショナル株式会社 | 茶抽出物、茶飲料及びそれらの製造方法 |
JP5282340B2 (ja) * | 2008-03-13 | 2013-09-04 | 長岡香料株式会社 | 天然素材の抗酸化作用および/またはリパーゼ阻害活性を増強させる方法、ならびに当該活性が増強された天然素材 |
WO2010073404A1 (ja) | 2008-12-26 | 2010-07-01 | 株式会社ニチレイバイオサイエンス | カシューアップルのプロアントシアニジン、プロアントシアニジン含有組成物、およびその用途 |
KR101991746B1 (ko) | 2011-10-04 | 2019-06-25 | (주)아모레퍼시픽 | 카테킨 생체 이용률 증진제 |
CN107304320B (zh) * | 2016-04-22 | 2021-08-13 | 马日专业涂层私人有限公司 | 有机亲水性涂料组合物、亲水性皮膜和换热器用铝材 |
JP6967261B2 (ja) * | 2017-03-01 | 2021-11-17 | 国立大学法人九州大学 | メタボリックシンドロームの予防又は改善用食品組成物及び医薬組成物 |
CN111065633A (zh) * | 2017-08-28 | 2020-04-24 | 株式会社Nbc纱网技术 | 多酚生产方法 |
KR101886802B1 (ko) | 2017-12-18 | 2018-08-08 | (주)아모레퍼시픽 | 카테킨 생체 이용률 증진제 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03219872A (ja) * | 1990-01-25 | 1991-09-27 | Meiji Seika Kaisha Ltd | リパーゼ阻害剤 |
JPH03228664A (ja) * | 1990-02-02 | 1991-10-09 | Meiji Seika Kaisha Ltd | 脂質の消化吸収抑制機能を有する食品 |
JPH09322710A (ja) * | 1996-06-03 | 1997-12-16 | Minato Seiyaku Kk | カテキン類を含有する茶抽出物の製造方法 |
JP4507027B2 (ja) * | 1998-12-04 | 2010-07-21 | 明治乳業株式会社 | Mmp阻害剤 |
-
2004
- 2004-06-21 JP JP2004182471A patent/JP5475938B2/ja active Active
-
2005
- 2005-06-20 ES ES05751348T patent/ES2571131T3/es active Active
- 2005-06-20 SG SG200904245-8A patent/SG153840A1/en unknown
- 2005-06-20 WO PCT/JP2005/011258 patent/WO2005123725A1/ja active Application Filing
- 2005-06-20 US US11/630,132 patent/US20110118344A1/en not_active Abandoned
- 2005-06-20 EP EP05751348.3A patent/EP1783127B1/en active Active
- 2005-06-20 CN CN2005800279080A patent/CN101094851B/zh active Active
- 2005-06-21 TW TW094120625A patent/TWI385166B/zh active
-
2007
- 2007-01-18 KR KR1020077001240A patent/KR101342288B1/ko not_active IP Right Cessation
-
2008
- 2008-03-06 HK HK08102623.3A patent/HK1108889A1/xx not_active IP Right Cessation
-
2011
- 2011-12-23 US US13/336,070 patent/US20120329862A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SG153840A1 (en) | 2009-07-29 |
TW200602343A (en) | 2006-01-16 |
JP2006001909A (ja) | 2006-01-05 |
EP1783127A4 (en) | 2010-06-23 |
TWI385166B (zh) | 2013-02-11 |
EP1783127A1 (en) | 2007-05-09 |
CN101094851A (zh) | 2007-12-26 |
US20110118344A1 (en) | 2011-05-19 |
US20120329862A1 (en) | 2012-12-27 |
ES2571131T3 (es) | 2016-05-24 |
KR101342288B1 (ko) | 2013-12-20 |
EP1783127B1 (en) | 2016-03-30 |
JP5475938B2 (ja) | 2014-04-16 |
KR20070027710A (ko) | 2007-03-09 |
CN101094851B (zh) | 2011-01-12 |
WO2005123725A1 (ja) | 2005-12-29 |
WO2005123725A9 (ja) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1108889A1 (en) | Novel compound having lipase inhibitory activity | |
PL1775298T3 (pl) | Pochodna tienopirazolowa wykazująca aktywność hamowania PDE7 | |
GB0422052D0 (en) | Enzymes | |
IL179020A0 (en) | Compounds for enzyme inhibition | |
EP1728792A4 (en) | 8-OXOADENINE COMPOUND | |
IL172777A0 (en) | Specific glucocoticosteroid compound having anti-inflammatory activity | |
EP1953145A4 (en) | HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY OF 11-HYDROXYSTEROID DEHYDROGENASE TYPE I | |
EP2172453A4 (en) | COMPOUND HAVING 11 ß-HSD1 INHIBITION ACTIVITY | |
PL1716099T3 (pl) | Haloalkilokarboksamidy do zwalczania mikroorganizmów | |
EP1798221A4 (en) | NITROGENIC HETEROCYCLIC 2-ARYLCARBOXYLENEAMIDE COMPOUND | |
HK1103643A1 (en) | Lipase inhibitor | |
SG10201403828PA (en) | Lipase inhibitors | |
IL183129A0 (en) | Lipase inhibitors | |
EP1767205A4 (en) | INHIBITORS OF LIPASE | |
GB0408771D0 (en) | Compound | |
HK1099687A1 (en) | Compounds having antitumor activity | |
IL177647A0 (en) | Use of enzyme | |
EP1753423A4 (en) | BENZO-NITROGEN WITH ANTIDIABETIC EFFECT | |
EP1704861A4 (en) | INHIBITOR OF LIPASE | |
GB0424565D0 (en) | Activity aid | |
GB0419595D0 (en) | Enzyme | |
GB0423688D0 (en) | Enzyme | |
GB0402302D0 (en) | Flex | |
GB0417372D0 (en) | Enzymes | |
GB0428024D0 (en) | Enzyme inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190620 |